Cancer type | mRNA/Protein | High/Low expression | Percentage | Clinical characteristics | remarks | ref |
---|---|---|---|---|---|---|
Glioma | mRNA and Protein | High | – | Positively correlated with WHO Grading; associated with poor median survival | – | [77] |
Medulloblastoma (MB) | Protein | High | 55% (31/56) in pediatric 67% (6/9) in adult | – | Mainly in cytoplasm | [79] |
Meningioma | Protein | High | – | Significantly higher in atypical meningiomas than in benign meningiomas | Mainly in cytoplasm | [83] |
Head and neck squamous cell carcinoma (HNSSC) | Protein Protein Protein | High High Low | 71% (15/21) 51% (217/423) 90% (290/324) | Associated with lymph node metastasis (N value), stage and poor patient survival Associated with shorter median survival (HR = 1.34, 95%CI = 1.00–1.81) in smokers Associated with male gender, smoking, alcohol consumption, betel quid chewing, poor RSF and poor OS; associated with poorer OS in non-smokers | Mainly in cytoplasm Subtype: 206 OSCC and 217 OPSSC; Mainly in cytoplasm Subtype: OSCC; Both in cytoplasm and nucleus | [29] [85] [49] |
Cutaneous squamous cell carcinoma (cSCC) | Protein | – | – | – | normal epidermis: mainly in nuclear; cSCC: mainly in cytoplasm | [20] |
Lung cancer | Protein mRNA Protein | high Low Low | 66% (63/94) 53% (73/138) 53% (76/144) | Associated with a shorter survival time (HR = 2.1, 95% CI; 1.13–3.93); a predictor of OS - Associated with a shorter median period of OS (HR = 1.61, 95%CI = 1.04–2.48) and RSF (HR = 1.78, 95%CI = 1.17–2.69) | Mainly in cytoplasm More common in E6 positive or P53 mutation samples; Associated with P21 and E-cadherin expression | [89] [26] [92] |
Breast cancer | Protein | High | 35% (127/366) | – | Cytoplasm; associated with hypoxia response | [95] |
Hepatocellular carcinoma (HCC) | mRNA Protein mRNA | High Low Low | 64% (29/45) 57% (49/86) 58% (26/45) | - More common in males and HBV-positive patients - | - - - | [90] [23] [20] |
Gallbladder carcinoma | Protein | High | 55% (69/126) | Associated with large tumor size, high TNM stage, lymph node metastasis, poor surgical curability and OS | Mainly in cytoplasm | [28] |
Pancreatic ductal adenocarcinoma (PDAC) | Protein | High | 52% (55/106) | Associated with poor differentiation, surrounding tissue and lymph node metastasis, advanced TMN stage, shorter survival and motility | Mainly in cytoplasm | [27] |
Colorectal cancer (CRC) | Protein Protein mRNA | High High Low | 41% (124/303) 53% (28/53) - | - - Prognostic predictive indicator (RNA sequencing, HR = 0.53; RNA microarray analysis, HR = 0.72); associated with poor OS and RFS, distant metastasis | Mainly in cytoplasm - - | [98] [99] [103] |
Prostate cancer | Protein | High | – | – | Both in cytoplasm and nuclear; positively associated with P21, androgen receptor (AR), PHD2, PHD3, CA9 | [104] |
Sarcoma | Protein | High | 61% (103/170) | – | Mainly in cytoplasm | [105] |